Search Results - "Jee-fu Huang"
-
1
Editorial: Revisit the causes and long‐term outcomes in cirrhosis patients
Published in Alimentary pharmacology & therapeutics (01-07-2024)“…LINKED CONTENT This article is linked to Tran et al papers. To view these articles, visit https://doi.org/10.1111/apt.18024 and…”
Get full text
Journal Article -
2
Modelling NAFLD disease burden in four Asian regions—2019‐2030
Published in Alimentary pharmacology & therapeutics (01-04-2020)“…Summary Background Non‐alcoholic fatty liver disease (NAFLD) and non‐alcoholic steatohepatitis (NASH) account for an increasing proportion of liver disease in…”
Get full text
Journal Article -
3
Association Between Fatty Liver and Cirrhosis, Hepatocellular Carcinoma, and Hepatitis B Surface Antigen Seroclearance in Chronic Hepatitis B
Published in The Journal of infectious diseases (15-07-2021)“…Abstract Background Chronic hepatitis B (CHB) and fatty liver (FL) are common, natural history data on concurrent FL and CHB (FL-CHB) are limited. This study…”
Get full text
Journal Article -
4
Editorial: PNPLA3 genotype and liver diseases—more than non‐alcoholic fatty liver disease
Published in Alimentary pharmacology & therapeutics (01-07-2020)“…LINKED CONTENT This article is linked to Mederacke et al and Mederacke and Mederacke papers. To view these articles, visit https://doi.org/10.1111/apt.15722…”
Get full text
Journal Article -
5
Liquid Biopsy for the Diagnosis of Viral Hepatitis, Fatty Liver Steatosis, and Alcoholic Liver Diseases
Published in International journal of molecular sciences (25-05-2020)“…During the progression from hepatitis to fibrosis, cirrhosis, and liver failure, the accumulation of stressed/damaged hepatocyte elements associated with liver…”
Get full text
Journal Article -
6
Prevalence, proportions of elevated liver enzyme levels, and long‐term cardiometabolic mortality of patients with metabolic dysfunction‐associated steatotic liver disease
Published in Journal of gastroenterology and hepatology (01-09-2024)“…Background and Aim This study estimated the prevalence of metabolic dysfunction‐associated steatotic liver disease (MASLD) according to cardiometabolic risk…”
Get full text
Journal Article -
7
Poor Diagnostic Efficacy of Noninvasive Tests for Advanced Fibrosis in Obese or Younger Than 60 Diabetic NAFLD patients
Published in Clinical gastroenterology and hepatology (01-04-2023)“…Serum-based noninvasive tests (NITs) have been widely used to assess liver fibrosis in patients with nonalcoholic fatty liver disease (NAFLD). However, the…”
Get full text
Journal Article -
8
Systematic integration of molecular and clinical approaches in HCV-induced hepatocellular carcinoma
Published in Journal of translational medicine (12-03-2024)“…MicroRNAs (miRNAs) play a crucial role in gene expression and regulation, with dysregulation of miRNA function linked to various diseases, including hepatitis…”
Get full text
Journal Article -
9
Letter to the Editor: Regional Epidemics of Nonalcoholic Fatty Liver Disease: Timing of Westernization and Ethnicity Matter
Published in Hepatology (Baltimore, Md.) (01-08-2020)Get full text
Journal Article -
10
Role of interleukin‐28B polymorphisms in the treatment of hepatitis C virus genotype 2 infection in Asian patients
Published in Hepatology (Baltimore, Md.) (01-01-2011)“…Genome‐wide association studies have linked single nucleotide polymorphisms (SNPs) near the interleukin‐28B gene to the hepatitis C virus genotype 1 (HCV‐1)…”
Get full text
Journal Article -
11
Impact of interleukin‐1β single nucleotide polymorphisms and depressive symptoms in individuals with chronic viral hepatitis
Published in The Kaohsiung journal of medical sciences (01-01-2024)“…Elevated levels of interleukin 1β (IL‐1β) have been identified in patients with chronic viral hepatitis and have been associated with depressive symptoms…”
Get full text
Journal Article -
12
The interplay of metabolic dysfunction‐associated fatty liver disease and viral hepatitis on liver disease severity: A large community‐based study in a viral endemic area
Published in Journal of gastroenterology and hepatology (01-01-2024)“…Background and Aim The prevalence of metabolic dysfunction‐associated fatty liver disease (MAFLD) and its interplay with hepatitis B virus (HBV) and hepatitis…”
Get full text
Journal Article -
13
Exosome‐derived differentiation antagonizing non‐protein coding RNA with risk of hepatitis C virus‐related hepatocellular carcinoma recurrence
Published in Liver international (01-05-2021)“…Background & Aims Differentiation antagonizing non‐protein coding RNA is associated with various types of neoplasms. Hepatitis C virus‐related hepatocellular…”
Get full text
Journal Article -
14
Time-Degenerative Factors and the Risk of Hepatocellular Carcinoma after Antiviral Therapy among Hepatitis C Virus Patients: A Model for Prioritization of Treatment
Published in Clinical cancer research (01-04-2017)“…Age and hepatic fibrosis are the factors that increase the risk of hepatocellular carcinoma over time. We aimed to explore their impact at the initiation of…”
Get full text
Journal Article -
15
Association of hyperuricemia with disease severity in chronic hepatitis C patients
Published in PloS one (05-11-2018)“…Hepatitis C virus (HCV) infection is associated with extrahepatic manifestations such as metabolic abnormalities. The association between chronic hepatitis C…”
Get full text
Journal Article -
16
The impact of body mass index on clinicopathological features of nonalcoholic fatty liver disease in Taiwan
Published in Journal of gastroenterology and hepatology (01-10-2022)“…Background and Aim The aim of this study was to assess the impact of body mass index (BMI) on the clinical and histological characteristics of patients with…”
Get full text
Journal Article -
17
Establishment of an outreach, grouping healthcare system to achieve microelimination of HCV for uremic patients in haemodialysis centres (ERASE-C)
Published in Gut (01-12-2021)“…HCV prevails in uremic haemodialysis patients. The current study aimed to achieve HCV microelimination in haemodialysis centres through a comprehensive…”
Get more information
Journal Article -
18
More advanced disease and worse survival in cryptogenic compared to viral hepatocellular carcinoma
Published in Liver international (01-05-2018)“…Background & Aims Although hepatitis B virus (HBV) and hepatitis C virus (HCV) infections remain major risk factors for hepatocellular carcinoma (HCC),…”
Get full text
Journal Article -
19
Air pollution associate with advanced hepatic fibrosis among patients with chronic liver disease
Published in The Kaohsiung journal of medical sciences (01-03-2024)“…We aimed to investigate the association between air pollution and advanced fibrosis among patients with metabolic associated fatty liver disease (MAFLD) and…”
Get full text
Journal Article -
20
On‐treatment gamma‐glutamyl transferase predicts the development of hepatocellular carcinoma in chronic hepatitis B patients
Published in Liver international (01-01-2022)“…Background & Aims Gamma‐glutamyl transferase (GGT) has been predictive of chronic hepatitis C‐related hepatocellular carcinoma (HCC) development. Its role in…”
Get full text
Journal Article